OBJECTIVE: The aim of this two-year prospective study was to determine which factors were: (i) directly related and/or (ii) indirectly related to multiple sclerosis (MS) relapse. These factors included life-event stressors, disease, demographic, psychosocial and lifestyle factors. BACKGROUND: Relatively little attention has been paid to the role of non-clinical relapse predictors (other than stressful life-events) in MS, or factors that indirectly impact on the stress-relapse relationship. METHODS: A total of 101 consecutive participants with MS were recruited from two MS clinics in Sydney, Australia. Stressful life-events, depression, anxiety and fatigue were assessed at study-entry and at three-monthly intervals for two years. Disease, demographic, psychosocial and lifestyle factors were assessed at baseline. Patient-reported relapses were recorded and corroborated by neurologists or evaluated against accepted relapse criteria. RESULTS: MS relapse was predicted by acute stressor frequency counts, coping responses that utilized social support, and being born in Australia, but not by chronic stressors, disease, demographic, psychosocial or lifestyle factors. No factors were found to indirectly impact on the stress relapse relationship. CONCLUSIONS: The number rather than severity of stressors was most important in relation to MS relapse risk, along with coping responses that utilized social support, suggesting that MS patients should avoid situations that are likely to generate multiple stressors or which provide few avenues for social support.
OBJECTIVE: The aim of this two-year prospective study was to determine which factors were: (i) directly related and/or (ii) indirectly related to multiple sclerosis (MS) relapse. These factors included life-event stressors, disease, demographic, psychosocial and lifestyle factors. BACKGROUND: Relatively little attention has been paid to the role of non-clinical relapse predictors (other than stressful life-events) in MS, or factors that indirectly impact on the stress-relapse relationship. METHODS: A total of 101 consecutive participants with MS were recruited from two MS clinics in Sydney, Australia. Stressful life-events, depression, anxiety and fatigue were assessed at study-entry and at three-monthly intervals for two years. Disease, demographic, psychosocial and lifestyle factors were assessed at baseline. Patient-reported relapses were recorded and corroborated by neurologists or evaluated against accepted relapse criteria. RESULTS: MS relapse was predicted by acute stressor frequency counts, coping responses that utilized social support, and being born in Australia, but not by chronic stressors, disease, demographic, psychosocial or lifestyle factors. No factors were found to indirectly impact on the stress relapse relationship. CONCLUSIONS: The number rather than severity of stressors was most important in relation to MS relapse risk, along with coping responses that utilized social support, suggesting that MS patients should avoid situations that are likely to generate multiple stressors or which provide few avenues for social support.
Authors: Erin E Young; Elisabeth G Vichaya; Nicole M Reusser; Jennifer L Cook; Andrew J Steelman; C Jane R Welsh; Mary W Meagher Journal: J Neuroimmunol Date: 2012-09-27 Impact factor: 3.478
Authors: Alison M Mackay; Robert Buckingham; Raymond S Schwartz; Suzanne Hodgkinson; Roy G Beran; Dennis J Cordato Journal: Int J MS Care Date: 2015 May-Jun
Authors: Farren B S Briggs; Selena E Bartlett; Benjamin A Goldstein; Joanne Wang; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen L Hauser; Jorge R Oksenberg; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Lisa F Barcellos Journal: Hum Mol Genet Date: 2010-08-10 Impact factor: 6.150
Authors: Erin E Young; Amy N Sieve; Elisabeth G Vichaya; Luis M Carcoba; Colin R Young; Andrew Ambrus; Ralph Storts; C Jane R Welsh; Mary W Meagher Journal: J Neuroimmunol Date: 2010-02-18 Impact factor: 3.478
Authors: Andrew J Steelman; Eric Alford; Colin R Young; Thomas H Welsh; Mary W Meagher; C Jane R Welsh Journal: Neuroimmunomodulation Date: 2009-11-17 Impact factor: 2.492
Authors: H R Linsenbardt; J L Cook; E E Young; E G Vichaya; C R Young; N M Reusser; R Storts; C J Welsh; M W Meagher Journal: J Neuroimmunol Date: 2015-09-12 Impact factor: 3.478